6533b871fe1ef96bd12d0ef7

RESEARCH PRODUCT

Additional file 1: of Safety and efficacy of afatinib as add-on to standard therapy of gemcitabine/cisplatin in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, phase I trial with an extensive biomarker program

Markus MoehlerAnnett MadererAnne EhrlichFriedrich FoersterArno SchadTanja NickolayChristian RuckesArndt WeinmannVisvakanth SivanathanJens MarquardtPeter GalleMarcus WoernsThomas Thomaidis

subject

description

Table S1. Main inclusion and exclusion criteria. Contains the main inclusion and exclusion criteria for patient selection in this study. (DOC 35 kb)

https://dx.doi.org/10.6084/m9.figshare.7580960.v1